In addition to reducing tumor-induced vascularization bevacizumab is also thought to exert direct anti-tumor activity against gliomas that express VEGF on their cell surface (12–15) and in animal models of ovarian cancer (16) and again the ability to quantify the activity of membrane bound VEGFA may also shed light on this process. Here, VEGFA is linked to ovarian carcinoma.